Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report

Author：            

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|5|2239-2243

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.5, 2015-01, pp. : 2239-2243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib

By                    

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 713-717

Spandidos Publications

Access to resources Recommend Favorite

Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance

By              

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 393-398

Spandidos Publications

Access to resources Recommend Favorite

Expression of Epidermal Growth Factor Receptor in Carcinoma of the Cervix

By Kim J.W.   Kim Y.T.   Kim D.K.   Song C.H.   Lee J.W.  

Gynecologic Oncology, Vol. 60, Iss. 2, 1996-02 ,pp. : 283-287

Academic Press

Access to resources Recommend Favorite

Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts

By          

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 923-928

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib in a patient with vaginal carcinoma and pulmonary metastasis: A case report

By          

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 805-806

Spandidos Publications

Access to resources Recommend Favorite